News
To be or not to be? Daily oral versus long-acting injectable medicines for HIV prevention BY SHOBHA SHUKLA – CNS To be or not to be? Daily oral versus long-acting injectable medicines for HIV ...
Supreme Court upholds Tennessee ban on gender-affirming care for transgender minors, huge setback for transgender rights.
Eva Mendes is revealing the unexpected thing she and Ryan Gosling connected over early in their relationship. She said in a ...
She loved her friends and cats fiercely and didn't let a second of life go by without savoring every last bit,” Guarnaschelli ...
Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...
America’s ambassador to Israel said Wednesday the United States is working to evacuate U.S. citizens from the country as an escalating conflict with Iran enters its sixth day.
New York Asian Film Festival (NYAFF) has unveiled the eight features that will compete for the Uncaged Award at its 24th ...
The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV ...
Yeztugo, generic name lenacapavir (LEN), has been approved after nearly eliminating the spread of HIV among trial patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results